testing showed that fungitoxicity against a range of potato
tuber pathogens was not only retained but enhanced. These
early results might not only lead to a dramatic reduction of
future fungicide applications, but should kick-start ionic liquid
research in crop protection.
Acknowledgements
Mark Wilson is thanked for technical assistance with the in vitro
sensitivity testing.
Notes and references
Fig. 1 In vitro activity of thiabendazolium docusate 3 against F.
coeruleum and F. sambucinum.
1 J. C. Peters, A. K. Lees, D. W. Cullen, L. Sullivan, G. P. Stroud and
A. C. Cunnington, Plant Pathol., 2008, 57, 262–271.
2 G. A. Hide, S. M. Hall and K. J. Boorer, Plant Pathol., 1988, 37,
377–380.
Table 2 Sensitivity of potato tuber pathogens to derivatives of imazalil
3 G. J. McKay and L. R. Cooke, FEMS Microbiol. Lett., 1997, 152,
371–378.
a
EC50 mM
4 G. Cayley, G. A. Hide, P. J. Read and Y. Dunne, Potato Res., 1983,
26, 163–173.
Isolate
2
4
5 Ionic Liquids in Synthesis, ed. P. Wasserscheid and T. Welton, Wiley-
F. sambucinum ex SASA
F. sambucinum L’gall 11
F. coeruleum ex B7/06 T8
F. culmorum P13
0.7
1.8
12.9
0.4
5.6
2.7
>127
>127
1.0
2.6
19.2
0.4
7.3
4.6
38.4
100.4
VCH, Weinheim, 2nd edn, 2008.
6 J. Ranke, S. Stolte, R. Stoermann, J. Arning and B. Jastorff, Chem.
Rev., 2007, 107, 2183–2206.
7 L. Carson, P. K. W. Chau, M. J. Earle, M. A. Gilea, B. F. Gilmore,
S. P. Gorman, M. T. McCann and K. R. Seddon, Green Chem., 2009,
11, 492–497.
Phoma exigua 9.1
Phoma foveata BL2/5 T3
P. erythroseptica BL2/08 P31
P. erythroseptica Rooster Eire
8 J. Pernak, K. Sobaszkiewicz and I. Mirska, Green Chem., 2003, 5,
52–56.
9 D. Demberelnyamba, K.-S. Kim, S. Choi, S.-Y. Park, H. Lee, C.-J.
Kim and I.-D. Yoo, Bioorg. Med. Chem., 2004, 12, 853–857.
10 J. Stoimenovski, D. R. MacFarlane, K. Bica and R. D. Rogers,
Pharm. Res., 2010, 27, 521–526.
11 W. L. Hough and R. D. Rogers, Bull. Chem. Soc. Jpn., 2007, 80,
2262–2269.
12 (a) K. Bica, C. Rijksen, M. Nieuwenheuzen and R. D. Rogers, Phys.
Chem. Chem. Phys., 2010, 12, 2011–2017; (b) K. Bica and R. D.
Rogers, Chem. Commun., 2010, 46, 1215–1217.
13 H. Hamamoto and Y. Miwa, PCT. Int. Appl. 2009075094A1, 2009.
Etodolac Patch (MRX-7EAT) became available for Phase I clinical
accessed 15/12/2009).
14 V. J. Kramer, D. G. Ouse, N. R. Pearson, H. Tank and M. W. Zetler,
U.S. Pat. Appl. 20080207452 A1, 2008.
15 R. D. Rogers, D. T. Daly, R. P. Swatloski, W. L. Hough, J. H. Davis,
M. Smiglak, J. Pernak and S. K. Spear, PCT Int. Appl. 2007044693,
2007.
16 W. L. Hough, M. Smiglak, H. Rodriguez, R. P. Swatloski, S. K. Spear,
D. T. Daly, J. Pernak, J. E. Grisel, R. D. Carliss, M. D. Soutullo, J. H.
Davis Jr. and R. D. Rogers, New J. Chem., 2007, 31, 1429–1436.
17 J. H. Davis, Jr and P. A. Fox, Chem. Commun., 2003, 1209–1212.
18 G. Liversidge, W. M. Eickhoff, K. J. Illig, P. Sarpotdar and S. B.
Ruddy, PCT Int. Appl. 9620735, 1996.
a Concentration required to reduce mycelial growth in vitro by 50%.
a second hydrophobic molecule such as stearic acid – that did
not lead to protonation and IL formation21 – did not enhance the
activity, as was observed for 3, but gave values similar to those of
thiabendazole alone. This behaviour might be explained by the
tendency of hydrophobic ILs to form ion pairs in solution, which
makes them inherently different from a simple co-formulation
of the active compounds with a second hydrophobic neutral.22
In a similar manner, imazalilium docusate 4 was tested at
127, 25, 12.7, 2.5 and 1.27 mM (equivalent to 0.5, 1, 5, 10 and
50 mg imazalil 2 per liter) against some of the same pathogen
isolates. Again, we observed that activity was retained with
EC50 values similar to those obtained with neutral imazalil
(Table 2). Imazalil, an inhibitor of fungal ergosterol synthesis, is
not active against Oomycete pathogens, but the hydrophobic IL
imazalilium docusate 4 showed some limited activity against P.
erythroseptica.
19 I. Legen, M. Salobir and J. Kerc, Int. J. Pharm., 2005, 291, 183–188.
20 J. H. Davis and K. J Forrester, Tetrahedron Lett., 1999, 40, 1621–
1622.
21 In contrast to 3 and 4, analytical data for the co-formulation of
thiabendazolium and stearic acid did not show any sign of IL or salt
formation. See: K. Bica, J. Shamshina, W. Hough, D. MacFarlane
and R. D. Rogers, Chem. Commun., 2011, 47, 2267–2269.
22 (a) K. J. Fraser, E. I. Izgorodina, M. Forsyth, J. L. Scott and D. R.
MacFarlane, Chem. Commun., 2007, 3817–3819; (b) D. F. Kennedy
and C. J. Drummond, J. Phys. Chem., 2009, 113, 5690–5693.
An IL strategy can be used for novel fungicide formulations
with increased hydrophobicity against potato tuber pathogens.
The basicity inherent in many fungicides, particularly in imi-
dazoles or benzimidazoles allows simple transformation into a
hydrophobic IL form in straightforward metathesis reactions
with hydrophobic anions such as the common emmolient
docusate. In addition to the potential for increased persistence
of these novel hydrophobic fungicide formulations, biological
2346 | Green Chem., 2011, 13, 2344–2346
This journal is
The Royal Society of Chemistry 2011
©